Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection.
Journal: Journal of viral hepatitis
Published: September 01, 2017
Efficacy of Sofosbuvir, Velpatasvir, and GS-9857 in Patients With Hepatitis C Virus Genotype 2, 3, 4, or 6 Infections in an Open-Label, Phase 2 Trial.
Journal: Gastroenterology
Published: May 23, 2016
Increased fat in pancreas not associated with risk of pancreatitis post-endoscopic retrograde cholangiopancreatography.
Journal: Clinical and experimental gastroenterology
Published: June 25, 2014
Triple therapy with boceprevir for HCV genotype 1 infection: phase III results in relapsers and nonresponders.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: January 04, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026